Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    January 2018
  1. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available


    December 2017
  2. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    PubMed     Text format     Abstract available


  3. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    PubMed     Text format     Abstract available


    October 2017
  4. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available


  5. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available


    September 2017
  6. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    PubMed     Text format     Abstract available


    August 2017
  7. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    PubMed     Text format     Abstract available


    July 2017
  8. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    PubMed     Text format    


  9. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available


    June 2017
  10. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Text format     Abstract available


    May 2017
  11. KOROUKIAN SM, Bakaki PM, Htoo PT, Han X, et al
    The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30720.
    PubMed     Text format     Abstract available


  12. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Text format     Abstract available


  13. SMALL W JR, Bacon MA, Bajaj A, Chuang LT, et al
    Cervical cancer: A global health crisis.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30667.
    PubMed     Text format     Abstract available


    April 2017
  14. ALSBEIH GA, Al-Harbi NM, Bin Judia SS, Khoja HA, et al
    Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Cancer. 2017 Apr 10. doi: 10.1002/cncr.30635.
    PubMed     Text format     Abstract available


    March 2017
  15. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


  16. BENEVOLO M, Allia E, Gustinucci D, Rollo F, et al
    Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
    Cancer. 2017;125:212-220.
    PubMed     Text format     Abstract available


    January 2017
  17. BRAR H, Hogen L, Covens A
    Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30509.
    PubMed     Text format     Abstract available


  18. BEAVIS AL, Gravitt PE, Rositch AF
    Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30507.
    PubMed     Text format     Abstract available


  19. DALTON HJ, Farley JH
    Racial disparities in cervical cancer: Worse than we thought.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30501.
    PubMed     Text format    


    December 2016
  20. OVESTAD IT, Dalen I, Hansen E, Loge JL, et al
    Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Cancer. 2016 Dec 5. doi: 10.1002/cncy.21807.
    PubMed     Text format     Abstract available


    November 2016
  21. FANG CY, Ma GX, Handorf EA, Feng Z, et al
    Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention.
    Cancer. 2016 Nov 21. doi: 10.1002/cncr.30391.
    PubMed     Text format     Abstract available


    October 2016
  22. THOMPSON B, Carosso EA, Jhingan E, Wang L, et al
    Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30399.
    PubMed     Text format     Abstract available


  23. PATADJI S, Li Z, Pradhan D, Zhao C, et al
    Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Cancer. 2016 Oct 24. doi: 10.1002/cncy.21791.
    PubMed     Text format     Abstract available


  24. DOXTADER EE, Brainard JA, Underwood D, Chute DJ, et al
    Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Cancer. 2016 Oct 12. doi: 10.1002/cncy.21783.
    PubMed     Text format     Abstract available


  25. LI Y, Zeng J, Huang M, An J, et al
    A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Cancer. 2016 Oct 3. doi: 10.1002/cncr.30328.
    PubMed     Text format     Abstract available


    September 2016
  26. SILVER MI, Schiffman M, Fetterman B, Poitras NE, et al
    The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30277.
    PubMed     Text format     Abstract available


  27. HUH WK, Andrews JC
    Cervical cancer screening: How do we make sense of it all and what is the right balance?
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30276.
    PubMed     Text format    


    May 2016
  28. WHOP LJ, Garvey G, Baade P, Cunningham J, et al
    The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
    Cancer. 2016;122:1560-9.
    PubMed     Text format     Abstract available


  29. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  30. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available


    February 2016
  31. ARMSTRONG K, Kim JJ, Halm EA, Ballard RM, et al
    Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Cancer. 2016 Feb 29. doi: 10.1002/cncr.29937.
    PubMed     Text format     Abstract available


    December 2015
  32. BYCHKOVSKY BL, Ferreyra ME, Strasser-Weippl K, Herold CI, et al
    Cervical cancer control in Latin America: A call to action.
    Cancer. 2015 Dec 15. doi: 10.1002/cncr.29813.
    PubMed     Text format     Abstract available


    November 2015
  33. RAMACHANDRAN A, Snyder FR, Katz ML, Darnell JS, et al
    Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Cancer. 2015;121:4016-24.
    PubMed     Text format     Abstract available


    October 2015
  34. TEMKIN SM, Seibel NL
    Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Cancer. 2015;121:3395-402.
    PubMed     Text format     Abstract available


    September 2015
  35. PRINTZ C
    HPV vaccine protects at multiple sites, even for some previously exposed.
    Cancer. 2015;121:2863.
    PubMed     Text format    


    August 2015
  36. BRAR H, Covens A
    Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details.
    Cancer. 2015;121:2674-7.
    PubMed     Text format    


    July 2015
  37. PRINTZ C
    Physicians say HPV testing alone can screen for cervical cancer.
    Cancer. 2015;121:2105.
    PubMed     Text format    


    June 2015
  38. HARIRI S, Johnson ML, Bennett NM, Bauer HM, et al
    Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
    Cancer. 2015 Jun 22. doi: 10.1002/cncr.29266.
    PubMed     Text format     Abstract available


    May 2015
  39. WEINMANN S, Williams AE, Kamineni A, Buist DS, et al
    Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.
    Cancer. 2015 May 18. doi: 10.1002/cncr.29445.
    PubMed     Text format     Abstract available


  40. PRINTZ C
    HPV vaccination rates remain low: Cancer prevention community needs to continue promoting the vaccine's safety and efficacy, say experts.
    Cancer. 2015;121:1341-3.
    PubMed     Text format    


  41. CHARLOT M, Santana MC, Chen CA, Bak S, et al
    Impact of patient and navigator race and language concordance on care after cancer screening abnormalities.
    Cancer. 2015;121:1477-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: